Indaptus amends bylaws to adopt universal proxy rules and exclusive federal forum

Indaptus Therapeutics, Inc.

Board adopted amended bylaws effective Jan 22, 2024, addressing universal proxy rules (Rule 14a-19 compliance).
Enhanced disclosure requirements for stockholder director nominations and business proposals.
Prohibits stockholder from submitting more director nominees than seats for election.
Requires proxy cards other than white for stockholders soliciting proxies.
Establishes federal district courts as exclusive forum for Securities Act claims.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Indaptus Therapeutics, Inc.: Amended and restated bylaws to address universal proxy rules, streamline stockholder nomination procedures, add exclusive forum provision, and make technical changes (effective 2024-01-22).

Change: bylaw amendment
Effective: 2024-01-22

Exact text from the filing

On January 22, 2024, the Board of Directors (the “ Board ”) of Indaptus Therapeutics, Inc., a Delaware corporation (the “ Company ”) approved and adopted amendments to the Company’s amended and restated bylaws (as amended, the “ Amended and Restated Bylaws ”), which became effective the same day.

View on SEC.gov

Browse all governance changes →

Indaptus Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-003441

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.